Pharmacogenomics Could Reduce Annual £2bn Cost Of Adverse Drug Reactions In UK

With more than 16% of hospital admissions in the UK caused by adverse drug reactions, costing the country upwards of £2bn a year, a genomics expert explains how pharmacogenomic tests could benefit both patients and the health care system.